Englisch, S. A., Meyer-Lindenberg, A., & Zink, M. (2016). Agomelatine for the treatment of major depressive episodes in schizophrenia-spectrum disorders: An open-prospective proof-of-concept study. Journal of clinical psychopharmacology, 36(6), . https://doi.org/10.1097/JCP.0000000000000587
Chicago-Zitierstil (17. Ausg.)Englisch, Susanne Angelika, Andreas Meyer-Lindenberg, und Mathias Zink. "Agomelatine for the Treatment of Major Depressive Episodes in Schizophrenia-spectrum Disorders: An Open-prospective Proof-of-concept Study." Journal of Clinical Psychopharmacology 36, no. 6 (2016). https://doi.org/10.1097/JCP.0000000000000587.
MLA-Zitierstil (9. Ausg.)Englisch, Susanne Angelika, et al. "Agomelatine for the Treatment of Major Depressive Episodes in Schizophrenia-spectrum Disorders: An Open-prospective Proof-of-concept Study." Journal of Clinical Psychopharmacology, vol. 36, no. 6, 2016, https://doi.org/10.1097/JCP.0000000000000587.